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ABSTRACTS -Oral 321A A n g io p la s ty an d R e s te n o s is : C linical Intraarterial irradiation reduces restenosis following experimental balioon angioplasty. Beta irradiation has the advantages of a markedly steeper dose decrease in tissue and less radioprotection problems, allowing its use in an ordinary catheterization laboratory. We developed a dedicated 90-Yttrium (90Y) pure beta-emitting source, in the form of a flexible coii (diameter 0,014" , length 22 mm} attached to the distal end of a 0.014" thrust wire. A segmented balloon consisting of four interconnected compartments (Schneider-Europe, AG) was developed to allow for intraarterial centering of the 90Y source, The tissue depth curve and dose variability on the surface of 1 ) conventional angioplasty balloons and 2) the centering balloon were studied using small thermoluminescent dosimeters. The tissue-depth dose cun/e for standard 2.5, 3, 3.5 and 4 mm balloons filled with contrast medium (Omnipaque 240) normalized to a surface dose of 1 0 Gy is presented in the figure. The standard deviations (percents of the mean) for the surface doses of 2.5, 3, 3.5, and 4 mm conventional PTC A balloons were 1.9 (13%), 5.5 (59%), 5.8 (73%), and 6,5 (110%) Gy, respectively. The mean, minimum and maximum doses on the surface of the 3.5 mm centering balloon were 8.4, 7.3, and 9,5 Gy (standard deviation 0.66 Gy, or 8% of the mean). Conclusions: 1 ) The tissue dose distribution of 90Y is well suited to the purpose of selective irradiation of the coronary arterial wall (thickness 0.3-0.8 m m )-for prevention of restenosis; 2) Homogeneous intramural dose delivery can be acheived with the help of a specially designed centering balloon. Radiolabeled mouse/human chimeric antibody Z2D3 specific for an antigen on proHferating'smooth muscle cells in human atheroma has been used to noninvasively visualize experimental atherosclerotic lesions in rabbits. Fur thermore, negative-charge polymer-mod if ¡cation of Z2D3 allowed enhanced target visualization with very high specific radioactivity and reduced back ground activity.
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Imaging of Human Atherosclerotic Lesions With In-111 Z2D3 Antibody Specific for Proliferating Smooth Muscle Cells in Human Atheroma
To evaluate its usefulness, negative charge-modified Z2D3 F (ab')2 was administered to 11 patients undergoing carotid endarterectomy. Each patient received 250 jjlg of Z2D3 labeled with 5 mCi of in-111 Lv. Serial gamma images, blood and urine samples were obtained for 72 H following injection. Carotid endarterectomy was performed within 48 H after the last imaging session. The sites of stenosis seen arteriographicaily were compared to location of the most intense antibody uptake. Endarterectomy specimens were imaged ex-vivo and then characterized immunohistochemically.
The concentration of the antibody was seen in all patients in the region of the carotid plaques. Uptake was focal and was best seen at 4 H. Intensity of uptake decreased over time. Whole body scans demonstrated localization in the kidneys, liver, and bone marrow which remained essentially unchanged.
No adverse reactions to the antibody were observed. Immunohistochemistry of endarterectomy specimens demonstrated specific localization of Z2D3 in the region of proliferating smooth muscle cells in the intima of the lesion.
The present study demonstrated the feasibility of nonEnvasive visualization of human atherosclerotic lesions. Further studies will be needed to optimize the imaging technique for potential clinical applications.
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To understand the mechanism of restenosis at the margins of Palmaz-Schatz stents, we compared serial intravascular ultrasound (IVUS) studies post stent implantation and follow-up (5.4 ± 3*8 months) in 88 lesions and analyzed reference {Ref: arterial, lumen, and plaque areas (in mm2); plaque burden (plaque/arterial area); remodeling (A arterial area); tissue growth ( A plaque area); and dissections} and stent margin {stent and intimal hyperplasia (IH) areas}. 29 lesions had focal restenosis involving one or both margins. Stent margin dissections were uncommon (4/88). There was no significant tissue growth (A plaque area) at the Ref sites or recoil (A stent area) of the stent margins. We conclude: Restenosis at the stent margin is common (33%) and is associated with implanting the edge of the stent within smaller, more diseased Ref vessels {smaller arterial, lumen, and stent areas; greater plaque burden). Superimposed Ref segment remodeling and neointimal tissue ac cumulation within smaller stent margins results in restenosis. These findings underlie the importance of anchoring edges of Palmaz-Schatz stents into healthy vessels with large lumens; this may require more extensive stenting to cover moderate proximal or distal stenoses. have been reviewed clinically and angiographically for 6 month follow-up: 10 patients were symptomatic (3 unstable and 7 stable angina). Angiography showed in 10/43 (23%) restenosis (diameter stenosis > 50%). No aneurys matic dilatation at the site of heparin delivery was observed, M ID measured by quantitative analysis system (CAAS II) in matched projections changed from 1.15 ± 0.36 mm (pre) through 2.03 ± 0.44 mm (post) to 1.75 ± 0.62 mm (at 6 month follow-up).
4:45 An Open Multicenter Registry to Evaluate Local Heparin Delivery Following Balloon Angioplasty for the Prevention of Restenosis: Preliminary Results
Local heparin
Matched group* p-value Acute gain (mm) 0.90 ± 0.46 0.90 ± 0 .4 6 NS Late loss (mm) 0.28 ± 0 .5 8 0.45 ± 0 .5 8 <0.05
* matched for vessel size, acute gain and lesion location
Nine patients (21%) required a re*PTCA and 1 patient required surgery (2%) of the treated segment, No myocardial infarction and no death were observed.
Conclusion: Local heparin delivery following balloon angioplasty by means of the coil-balloon may reduce on longterm the incidence of restenosis and decrease the need for re-vascularization.
